Environment

We have always treated the environmental aspects of our activities sensitively. We have chosen to focus on key ways our facilities, products and services impact the environment.

As a sustainable company, we prioritize continuous improvement. This means we constantly review our processes to minimize the waste of resources. The result is a smaller environmental impact, with more efficient processes, better finances, a better customer offering and a contribution to society in terms of sustainable development.

The Global Goals and the 2030 Agenda for Sustainable Development

We have signed up to the 17 UN Global Goals and the 2030 Agenda for Sustainable Development.

Based on the expectations of ua as a state-owned company, our mission, our connection to the UN Global Compact and Fossil Free Sweden initiatives, as well as our stakeholders’ expectations and ambitions, we have chosen to prioritize six of the goals:

  • Good health and well-being (Goal 3)
  • Clean water and sanitation (Goal 6)
  • Affordable and clean energy (Goal 7)
  • Decent work and economic growth (Goal 8)
  • Responsible consuption and production (Goal 12)
  • Climate action (Goal 13)

Based on these, we have formulated four long-term goals for sustainable growth and profitability to achieve by 2030:

  1. Develop and provide a quality-assured and medically purposeful range of individualized extemporaneous drugs (Goal 3)
  2. Create growth with increased productivity and be an attractive employer that continually develops our employees’ skills in an equitable environment that promotes diversity (Goal 8)
  3. Reduce the use of fossil fuel-based energy sources and logistics services, and minimize resource use and emissions in our production (Goals 12, 13)
  4. Actively ensure that employees and suppliers follow the APL Ethical Guidelines and Code of Conduct and actively protect human rights, with zero tolerance for corruption and bribery (Goal 8).

 

Work to reduce waste

Our goal is to reduce the overall amount of waste, including medical waste, and to increase the proportion of recycled waste. This contributes to Sweden’s environmental goals through:

  • reduced emissions of carbon dioxide when fossil components are burned (limited climate impact)
  • reduced creation of hazardous waste and risk of polluting land and groundwater when waste is stored and processed (poison-free environment)
  • reduced creation of waste (good developed environment).

In this way, we also contribute to the UN’s goals of sustainable consumption and production (Goal 12).

Interventions to reduce energy consumption

APL is one of the actors in the Fossil Free Sweden initiative, and we have taken a powerful charge of our energy consumption to reduce carbon dioxide emissions. For example, we have initiated detailed energy mapping of the company’s activities and installed separate meters to facilitate follow-up steps based on our energy consumption data.

Orderläggning

Extemporeläkemedel och lagerberedningar

Beställ online via EbEx

Kundservice

Telefon: 010-447 97 00
e-post: kundservice@apl.se

 

Ordinarie öppettider:
Helgfria vardagar 08:00-17:00.

 

Öppettider sommar:
Helgfria vardagar 08:00-16:00.

Gäller 24 juni-16 augusti 2024.

 

Reservrutin

Reservrutinen används endast för akuta medicinskt viktiga beställningar av extemporeläkemedel under tiden EbEx ordersystem inte kan nås. För att kunna använda dig av rutinen så krävs det att du redan är befintlig kund hos APL och har ett kundnummer.

Beställningar görs på för ändamålet avsedd blankett och får inte innehålla några patientuppgifter.

Beställningen skickas via e-post till kundservice@apl.se.


 

Contact

Visiting adress:

Prismavägen 2, Kungens Kurva


+46 10 447 96 00


Other contact information

About APL

Apotek Produktion & Laboratorier (APL) is one of Europe’s leading companies manufacturing extemporaneous drugs and stock preparations. We have a public policy assignment from the Swedish government, but also work together with other pharmaceutical companies to create the greatest possible patient benefit. The assignment also comprises preparedness to maintain operations in times of crisis and ultimately war.

Our vision is that we will make a difference for patients with additional needs. We are also an established contract manufacturer within life science in Scandinavia, where we deliver services within development and analysis. With more than 500 employees and five manufacturing units in Malmö, Gothenburg, Stockholm and Umeå, we develop drugs that improve and save lives.


Read more